{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:15:11Z","timestamp":1786947311551,"version":"build-2736575974"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,21]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Xylazine has emerged in recent years as a dangerous adulterant in illicit fentanyl use, and methods for the detection of xylazine in toxicology panels are still lagging. We developed methods for the screening and quantitation of xylazine in oral fluid (OF), a popular testing medium due to its ease of collection and reflection of presence in blood for many classes of drugs. Enzyme-linked immunosorbent assays were employed for the rapid screening of xylazine directly from the collection device buffer with a cutoff of 1\u2009ng\/mL. Solid-phase extraction coupled with liquid chromatography\u2013tandem mass spectrometry facilitated the confirmation and quantification of xylazine as low as 0.1\u2009ng\/mL and a dynamic range of 0.1\u201325\u2009ng\/mL. Selectivity, ionization suppression, processed sample stability, and dilution effect were also assessed. The method was validated through the American National Standards Institute\/American Academy of Forensic Sciences Standards Board (ANSI\/ASB) Standard 036, first edition from 2019, and found to be accurate, precise, and robust. Living human subject OF samples collected within substance use disorder and therapeutic drug monitoring clinics received between September 2023 and January 2024, with the specific request to test for xylazine (n\u2009=\u200957), were screened. Presumptive positive samples were confirmed using the validated method. Xylazine confirmed living human subject OF sample concentrations ranged from 1.2 to 23.3\u2009ng\/mL.<\/jats:p>","DOI":"10.1093\/jat\/bkae055","type":"journal-article","created":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T15:23:31Z","timestamp":1720884211000},"page":"482-488","source":"Crossref","is-referenced-by-count":6,"title":["Qualitative and quantitative determination of xylazine in oral fluid"],"prefix":"10.1093","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0976-6646","authenticated-orcid":false,"given":"Matthew","family":"Levitas","sequence":"first","affiliation":[{"name":"Forensic Fluids Laboratories , 225 Parsons Street, Kalamazoo, MI 49007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Thomas","sequence":"additional","affiliation":[{"name":"Forensic Fluids Laboratories , 225 Parsons Street, Kalamazoo, MI 49007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Widman","sequence":"additional","affiliation":[{"name":"Forensic Fluids Laboratories , 225 Parsons Street, Kalamazoo, MI 49007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"DeColumna","sequence":"additional","affiliation":[{"name":"Forensic Fluids Laboratories , 225 Parsons Street, Kalamazoo, MI 49007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandi","family":"Allgaier","sequence":"additional","affiliation":[{"name":"Forensic Fluids Laboratories , 225 Parsons Street, Kalamazoo, MI 49007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Conley","sequence":"additional","affiliation":[{"name":"Forensic Fluids Laboratories , 225 Parsons Street, Kalamazoo, MI 49007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy","family":"deHagen","sequence":"additional","affiliation":[{"name":"Forensic Fluids Laboratories , 225 Parsons Street, Kalamazoo, MI 49007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Freitas","sequence":"additional","affiliation":[{"name":"Forensic Fluids Laboratories , 225 Parsons Street, Kalamazoo, MI 49007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Horvath","sequence":"additional","affiliation":[{"name":"Forensic Fluids Laboratories , 225 Parsons Street, Kalamazoo, MI 49007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Lemberg","sequence":"additional","affiliation":[{"name":"Forensic Fluids Laboratories , 225 Parsons Street, Kalamazoo, MI 49007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Lemberg","sequence":"additional","affiliation":[{"name":"Forensic Fluids Laboratories , 225 Parsons Street, Kalamazoo, MI 49007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,20]]},"reference":[{"key":"2024082121410193400_R1","first-page":"503","article-title":"Xylazine-related deaths\u2014Cook County, Illinois, 2017\u20132021","volume":"71","author":"Chhabra","year":"2022","journal-title":"MMWR"},{"key":"2024082121410193400_R2","first-page":"28","article-title":"A fatal intoxication with xylazine","volume":"24","author":"Briellmann","year":"1994","journal-title":"Bull Intl Assoc Forensic Toxicol"},{"key":"2024082121410193400_R3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2885.1988.tb00189.x","article-title":"Xylazine\u2014a review of its pharmacology and use in veterinary medicine","volume":"11","author":"Greene","year":"1988","journal-title":"J Vet Pharmacol Ther"},{"key":"2024082121410193400_R4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2021.111083","article-title":"Analysis of drug residue in needle-exchange syringes in Washington, D.C","volume":"329","author":"Evans","year":"2021","journal-title":"Forensic Sci Int"},{"key":"2024082121410193400_R5","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jat\/bkac049","article-title":"Xylazine: pharmacology review and prevalence and drug combinations in forensic toxicology casework","volume":"46","author":"Kacinko","year":"2022","journal-title":"J Anal Toxicol"},{"key":"2024082121410193400_R6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/injuryprev-2020-043968","article-title":"Increasing presence of xylazine in heroin and\/or fentanyl deaths, Philadelphia, Pennsylvania, 2010-2019","volume":"27","author":"Johnson","year":"2021","journal-title":"Inj Prev"},{"key":"2024082121410193400_R7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1556-4029.2007.00648.x","article-title":"Concurrent detection of heroin, fentanyl, and xylazine in seven drug-related deaths reported from the Philadelphia Medical Examiner\u2019s Office","volume":"53","author":"Wong","year":"2008","journal-title":"J Forensic Sci"},{"key":"2024082121410193400_R8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0379-0738(03)00083-5","article-title":"A reported case involving impaired driving following self-administration of xylazine","volume":"134","author":"Stillwell","year":"2003","journal-title":"Forensic Sci Int"},{"key":"2024082121410193400_R9","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/1556-4029.13684","article-title":"Use of xylazine in drug-facilitated crimes","volume":"63","author":"Krongvorakul","year":"2018","journal-title":"J Forensic Sci"},{"key":"2024082121410193400_R10","article-title":"Biden-\u2060Harris Administration Designates Fentanyl Combined with Xylazine as an Emerging Threat to the United States","author":"The White House","year":"2023"},{"key":"2024082121410193400_R11","article-title":"Notice of Special Interest (NOSI): Xylazine: Understanding Its Use and the Consequences (2023) Bethesda","author":"National Institutes of Health"},{"key":"2024082121410193400_R12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00006565-200112000-00012","article-title":"Severe intoxication from xylazine inhalation","volume":"17","author":"Capraro","year":"2001","journal-title":"Pediatr Emerg Care"},{"key":"2024082121410193400_R13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00063110-200309000-00022","article-title":"Drug abuse with inhalated xylazine","volume":"10","author":"Elejalde","year":"2003","journal-title":"Eur J Emerg Med"},{"key":"2024082121410193400_R14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jemermed.2015.09.051","article-title":"Xylazine exposures reported to Texas poison centers","volume":"51","author":"Forrester","year":"2016","journal-title":"J Emergency Med"},{"key":"2024082121410193400_R15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2014.03.015","article-title":"Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: a comprehensive review of the literature","volume":"240","author":"Ruiz-Col\u00f3n","year":"2014","journal-title":"Forensic Sci Int"},{"key":"2024082121410193400_R16","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2105\/AJPH.2022.306881","article-title":"Xylazine and overdoses: trends, concerns, and recommendations","volume":"112","author":"Alexander","year":"2022","journal-title":"Am J Public Health"},{"key":"2024082121410193400_R17","first-page":"1","article-title":"Enhancing fentanyl antinociception and preventing tolerance with \u03b1-2 adrenoceptor agonists in rats","volume":"457","author":"Pehlivan","year":"2024","journal-title":"Behav Brain Res"},{"key":"2024082121410193400_R18","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMp2303120","article-title":"Xylazine\u2014medical and public health imperatives","volume":"388","author":"Gupta","year":"2023","journal-title":"N Engl J Med"},{"key":"2024082121410193400_R19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/jat\/31.3.165","article-title":"Solid-phase extraction and gas chromatographic-mass spectrometric determination of the veterinary drug xylazine in human blood","volume":"31","author":"Barroso","year":"2007","journal-title":"J Anal Toxicol"},{"key":"2024082121410193400_R20","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/jat\/bkv040","article-title":"Simultaneous determination of xylazine and 2,6-xylidine in blood and urine by auto solid-phase extraction and ultra high performance liquid chromatography coupled with quadrupole-time of flight mass spectrometry","volume":"39","author":"Gao","year":"2015","journal-title":"J Anal Toxicol"},{"key":"2024082121410193400_R21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/ADM.0000000000001132","article-title":"Widespread distribution of xylazine detected throughout the United States in healthcare patient samples","volume":"17","author":"Holt","year":"2023","journal-title":"J Addict Med"},{"key":"2024082121410193400_R22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-023-00867-x","article-title":"Public health impact and harm reduction implications of xylazine-involved overdoses: a narrative review","volume":"20","author":"Zhu","year":"2023","journal-title":"Harm Reduct J"},{"key":"2024082121410193400_R23","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1515\/cclm-2023-0343","article-title":"Recent advances of drugs monitoring in oral fluid and comparison with blood","volume":"61","author":"Casati","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"2024082121410193400_R24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.forsciint.2005.02.028","article-title":"Oral fluid collection: the neglected variable in oral fluid testing","volume":"150","author":"Crouch","year":"2005","journal-title":"Forensic Sci Int"},{"key":"2024082121410193400_R25","first-page":"203","article-title":"Introduction and review of collection techniques and applications of drug testing of oral fluid","volume":"30","author":"Drummer","year":"2008","journal-title":"Ther Drug Monit"},{"key":"2024082121410193400_R26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2023.110876","article-title":"Validity and reliability of in-person and remote oral fluids drug testing compared to urine drug testing","volume":"250","author":"Khazanov","year":"2023","journal-title":"Drug Alcohol Depend"},{"key":"2024082121410193400_R27","article-title":"Drug testing in oral fluid","volume":"27","author":"Drummer","year":"2006","journal-title":"Clin Biochem Rev"},{"key":"2024082121410193400_R28","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1515\/CCLM.2004.248","article-title":"Oral fluid as a diagnostic tool","volume":"42","author":"Choo","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"2024082121410193400_R29","first-page":"1","article-title":"Oral fluid in DUID cases","volume":"23","author":"Moore","year":"2015","journal-title":"National Traffic Law Center"},{"key":"2024082121410193400_R30","first-page":"1","article-title":"A comparison of urine and oral fluid drug testing","volume":"9","author":"Smiley","year":"2019","journal-title":"J Clin Toxicol"},{"key":"2024082121410193400_R31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.4155\/bio-2023-0122","article-title":"The potential of oral fluid in drug monitoring: an update","volume":"15","author":"Gallardo","year":"2023","journal-title":"Bioanalysis"},{"key":"2024082121410193400_R32","doi-asserted-by":"crossref","DOI":"10.1016\/j.aap.2022.106694","article-title":"Correlation between oral fluid and blood THC concentration: a systematic review and discussion of policy implications","volume":"173","author":"Robertson","year":"2022","journal-title":"Accid Anal Prev"},{"key":"2024082121410193400_R33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/dta.1532","article-title":"Comparison of drug concentrations between whole blood and oral fluid","volume":"6","author":"Langel","year":"2014","journal-title":"Drug Test Anal"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkae055\/58536436\/bkae055.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/48\/7\/482\/58875952\/bkae055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/48\/7\/482\/58875952\/bkae055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T04:03:22Z","timestamp":1732248202000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/48\/7\/482\/7713365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,20]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,6,20]]},"published-print":{"date-parts":[[2024,8,21]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkae055","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,6,20]]}}}